Jennifer Law - Concepedia

Author

Jennifer Law

University of British Columbia

Also Known As

Jennifer H Law, Jennifer H. Law, Jennifer Law, Law, Jennifer, Paul Kruszka

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

University of British Columbia BC Cancer Agency Princess Margaret Cancer Centre University Health Network Child and Family Research Institute

About

Jennifer Law is an author at University of British Columbia specializing in medicine, molecular diagnostics, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	394
2	Public Health	3	3	173
3	Engineering	2	2	145
4	Natural Sciences	1	1	46
5	Biostatistics	1	1	124

Jennifer Law

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival Jennifer Law, Golareh Habibi, Kaiji Hu, Cancer Research	2008	404
Y-Box Binding Protein-1 Induces the Expression of <i>CD44</i> and <i>CD49f</i> Leading to Enhanced Self-Renewal, Mammosphere Growth, and Drug Resistance Karen To, Abbas Fotovati, Kristen M. Reipas, Cancer Research	2010	166
Analytical and Preanalytical Biases in Serum Proteomic Pattern Analysis for Breast Cancer Diagnosis Aly Karsan, Bernhard J. Eigl, Stéphane Flibotte, Clinical Chemistry EngineeringPathologyTumor MarkersOvarian CancerProteomic Technology	2005	124
Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes Golareh Habibi, Samuel Leung, Jennifer Law, Breast Cancer Research	2008	122
The evolution of geographic parthenogenesis in <i>Timema</i> walking‐sticks Jennifer Law, Bernard J. Crespi Molecular Ecology	2002	122
Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial Darrel Cook, Mel Krajden, Adam R. Brentnall, International Journal of Cancer Hpv FocalDiagnosisGynecologyPathologyCytopathology	2018	94
Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells Kaiji Hu, Jennifer Law, Abbas Fotovati, Breast Cancer Research	2012	88
Luteolin is a novel p90 ribosomal S6 kinase (RSK) inhibitor that suppresses Notch4 signaling by blocking the activation of Y-box binding protein-1 (YB-1) Kristen M. Reipas, Jennifer Law, Nicole Couto, Oncotarget Molecular PharmacologyProtein Quality ControlNotch4 PromoterSignal TransductionSignaling Pathway	2013	59
Association of Circulating Tumor DNA Testing Before Tissue Diagnosis With Time to Treatment Among Patients With Suspected Advanced Lung Cancer Miguel García-Pardo, Kasia Czarnecka‐Kujawa, Jennifer Law, JAMA Network Open	2023	57
Molecular Decoy to the Y-Box Binding Protein-1 Suppresses the Growth of Breast and Prostate Cancer Cells whilst Sparing Normal Cell Viability Jennifer Law, Yvonne Li, Karen To, PLoS ONE	2010	50

Page 1